Section #4 is intended to identify clinical laboratories or testing facilities directly
contributing to or supporting the clinical study (for example, diagnostic labs performing
blood work, imaging centers, cardiology labs, etc.). This may include analytical labs that
provide pharmacokinetic analysis, and laboratories supplying efficacy data for clinical
investigations conducted under an IND.
